• Breathe BioMedical expanded its multi-center observational study of a breath test for early breast cancer detection in women with dense breasts, adding Weinstein Imaging Associates in Pittsburgh as a new clinical site.
• Breath samples collected at the site will be used to refine pattern-based detection aimed at supporting mammography in a population where imaging can miss cancers.
• Preliminary proof-of-concept results were already presented, showing the approach could distinguish between women with early-stage breast cancer and those without the disease.
• Study readout will be presented in the future, focusing on overall diagnostic performance and error rates to support further development of the platform.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Breathe Biomedical Inc. published the original content used to generate this news brief on May 05, 2026, and is solely responsible for the information contained therein.